Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
3
×
boston blog main
inclisiran
3
×
life sciences
medicines co.
3
×
national blog main
new york blog main
new york top stories
regeneron pharmaceuticals
alirocumab
boston top stories
boulder/denver blog main
boulder/denver top stories
cholesterol
detroit blog main
detroit top stories
evercore isi
evolocumab
heart attack
indiana blog main
indiana top stories
medco
national
national top stories
pcsk9
praluent
raleigh-durham blog main
raleigh-durham top stories
repatha
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
stroke
texas blog main
texas top stories
trial
What
cholesterol
drug
lowering
new
abbvie’s
alnylam
barbecuing
based
bio
camping
cardiologist
center
check
conference
data
day
drugs
evidence
expensive
faces
financial
flop
foe
healthcare
heart
hint
hit
inhibitors
j
j’s
known
labor
lasting
long
looms
medco
medicines
monday
opioid
paris
Language
unset
Current search:
inclisiran
×
biotech
×
" medicines co. "
×
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms